Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
There are no licensed vaccines against Plasmodium vivax. We conducted two Phase I/IIa clinical trials to assess two vaccines targeting P. vivax Duffy-binding protein region II (PvDBPII). Recombinant viral vaccines using chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) vecto...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Association for the Advancement of Science
2023
|
| _version_ | 1797110253162070016 |
|---|---|
| author | Hou, M Barrett, JR Themistocleous, Y Rawlinson, TA Diouf, A Martinez, FJ Nielsen, CM Lias, AM King, LDW Edwards, NJ Greenwood, NM Kingham, L Poulton, I Khozoee, B Goh, C Hodgson, SH Mac lochlainn, D Salkeld, J Guillotte-Blisnick, M Huon, C Mohring, F Reimer, JM Chauhan, VS Biswas, S Lawrie, AM Silk, SE Minassian, AM Draper, SJ Mukherjee, P Taylor, IJ Cho, J Nugent, FL Long, CA Moon, RW Miura, K Chitnis, CE |
| author_facet | Hou, M Barrett, JR Themistocleous, Y Rawlinson, TA Diouf, A Martinez, FJ Nielsen, CM Lias, AM King, LDW Edwards, NJ Greenwood, NM Kingham, L Poulton, I Khozoee, B Goh, C Hodgson, SH Mac lochlainn, D Salkeld, J Guillotte-Blisnick, M Huon, C Mohring, F Reimer, JM Chauhan, VS Biswas, S Lawrie, AM Silk, SE Minassian, AM Draper, SJ Mukherjee, P Taylor, IJ Cho, J Nugent, FL Long, CA Moon, RW Miura, K Chitnis, CE |
| author_sort | Hou, M |
| collection | OXFORD |
| description | There are no licensed vaccines against Plasmodium vivax. We conducted two Phase I/IIa clinical trials to assess two vaccines targeting P. vivax Duffy-binding protein region II (PvDBPII). Recombinant viral vaccines using chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) vectors, as well as a protein and adjuvant formulation (PvDBPII/Matrix-M) were tested in both a standard and delayed dosing regimen. Volunteers underwent controlled human malaria infection (CHMI) following their last vaccination, alongside unvaccinated controls. Efficacy was assessed by comparison of parasite multiplication rate in blood. PvDBPII/Matrix-M, given in a delayed dosing regimen, elicited the highest antibody responses and reduced the mean parasite multiplication rate following CHMI by 51% (n=6) compared to unvaccinated controls (n=13), whereas no other vaccine or regimen impacted parasite growth. Both viral-vectored and protein vaccines were well tolerated and elicited expected, short lived adverse events. Together, these results support further clinical evaluation of the PvDBPII/Matrix-M P. vivax vaccine. |
| first_indexed | 2024-03-07T07:52:24Z |
| format | Journal article |
| id | oxford-uuid:0bf0b660-741b-41dc-a6fd-a93af397c878 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:52:24Z |
| publishDate | 2023 |
| publisher | American Association for the Advancement of Science |
| record_format | dspace |
| spelling | oxford-uuid:0bf0b660-741b-41dc-a6fd-a93af397c8782023-07-27T07:56:04ZVaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infectionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0bf0b660-741b-41dc-a6fd-a93af397c878EnglishSymplectic ElementsAmerican Association for the Advancement of Science2023Hou, MBarrett, JRThemistocleous, YRawlinson, TADiouf, AMartinez, FJNielsen, CMLias, AMKing, LDWEdwards, NJGreenwood, NMKingham, LPoulton, IKhozoee, BGoh, CHodgson, SHMac lochlainn, DSalkeld, JGuillotte-Blisnick, MHuon, CMohring, FReimer, JMChauhan, VSBiswas, SLawrie, AMSilk, SEMinassian, AMDraper, SJMukherjee, PTaylor, IJCho, JNugent, FLLong, CAMoon, RWMiura, KChitnis, CEThere are no licensed vaccines against Plasmodium vivax. We conducted two Phase I/IIa clinical trials to assess two vaccines targeting P. vivax Duffy-binding protein region II (PvDBPII). Recombinant viral vaccines using chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) vectors, as well as a protein and adjuvant formulation (PvDBPII/Matrix-M) were tested in both a standard and delayed dosing regimen. Volunteers underwent controlled human malaria infection (CHMI) following their last vaccination, alongside unvaccinated controls. Efficacy was assessed by comparison of parasite multiplication rate in blood. PvDBPII/Matrix-M, given in a delayed dosing regimen, elicited the highest antibody responses and reduced the mean parasite multiplication rate following CHMI by 51% (n=6) compared to unvaccinated controls (n=13), whereas no other vaccine or regimen impacted parasite growth. Both viral-vectored and protein vaccines were well tolerated and elicited expected, short lived adverse events. Together, these results support further clinical evaluation of the PvDBPII/Matrix-M P. vivax vaccine. |
| spellingShingle | Hou, M Barrett, JR Themistocleous, Y Rawlinson, TA Diouf, A Martinez, FJ Nielsen, CM Lias, AM King, LDW Edwards, NJ Greenwood, NM Kingham, L Poulton, I Khozoee, B Goh, C Hodgson, SH Mac lochlainn, D Salkeld, J Guillotte-Blisnick, M Huon, C Mohring, F Reimer, JM Chauhan, VS Biswas, S Lawrie, AM Silk, SE Minassian, AM Draper, SJ Mukherjee, P Taylor, IJ Cho, J Nugent, FL Long, CA Moon, RW Miura, K Chitnis, CE Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title | Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title_full | Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title_fullStr | Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title_full_unstemmed | Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title_short | Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection |
| title_sort | vaccination with plasmodium vivax duffy binding protein inhibits parasite growth during controlled human malaria infection |
| work_keys_str_mv | AT houm vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT barrettjr vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT themistocleousy vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT rawlinsonta vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT dioufa vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT martinezfj vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT nielsencm vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT liasam vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT kingldw vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT edwardsnj vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT greenwoodnm vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT kinghaml vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT poultoni vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT khozoeeb vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT gohc vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT hodgsonsh vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT maclochlainnd vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT salkeldj vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT guillotteblisnickm vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT huonc vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT mohringf vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT reimerjm vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT chauhanvs vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT biswass vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT lawrieam vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT silkse vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT minassianam vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT drapersj vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT mukherjeep vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT taylorij vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT choj vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT nugentfl vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT longca vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT moonrw vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT miurak vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection AT chitnisce vaccinationwithplasmodiumvivaxduffybindingproteininhibitsparasitegrowthduringcontrolledhumanmalariainfection |